Minimal residual disease negativity predicts time to next treatment in multiple myeloma
For patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTNT), according to a study published online ...
Mar 22, 2023
0
2